Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Shockwave Medical Inc (NQ: SWAV )

330.52 +0.52 (+0.16%)
Streaming Delayed Price Updated: 2:07 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Shockwave Medical Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Where ShockWave Medical Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
ShockWave Medical (SWAV) Q3 2022 Earnings Call Transcript
SWAV earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Shockwave Medical Reports Third Quarter 2022 Financial Results
From Shockwave Medical, Inc.
Via GlobeNewswire
Earnings Preview: ShockWave Medical
ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that ShockWave... 
Via Benzinga
Best and Worst Performing Stocks Since Rate Hikes Began
Looking at the S&P 1500, which includes large-caps, mid-caps, and small-caps, the average stock in the index is down 7.1% since the close on March 16th after the first rate hike. 
Via Talk Markets
4 Analysts Have This to Say About ShockWave Medical
  Within the last quarter, ShockWave Medical (NASDAQ:SWAV) has observed the following analyst ratings: 
Via Benzinga
Recap: ShockWave Medical Q2 Earnings
  ShockWave Medical (NASDAQ:SWAV) reported its Q2 earnings results on Monday, August 8, 2022 at 04:02 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. 
Via Benzinga
Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease
Disrupt PAD III Observational Study Results Confirm Safety and Effectiveness of IVL in Patients with Complex Calcified Lesions 
From Shockwave Medical, Inc.
Via GlobeNewswire
Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest
Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point. 
Via InvestorPlace
Nasdaq Bear Market: 3 Growth Stocks You'll Regret Not Buying at Knocked-Down Prices
Scooping up shares of these fast-growing businesses on the dip could do wonders for your portfolio over time. 
Via The Motley Fool
Opportunities In Large Cap Growth And Small Cap
The third quarter was true 
Via Talk Markets
Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results
From Shockwave Medical, Inc.
Via GlobeNewswire
7 Little-Known Stocks With Millionaire-Maker Potential
The unprecedented number of tech revolutions has made it easier than ever to identify many potential millionaire-maker stocks to buy. 
Via InvestorPlace
Eli Lilly Leads 5 Stocks To Watch In Bear Market
Eli Lilly is holding up, while others crumbled Friday amid the market sell-off. 
Via Investor's Business Daily
2 Medical Device Makers Crushing the Market
One company is an industry disruptor with big upside potential, while the other is a huge, diversified company. 
Via The Motley Fool
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year
Biotech isn't the only place to make money in health care this year. 
Via Investor's Business Daily
Cutera Stock Earns Relative Strength Rating Upgrade
On Monday, medical aesthetic Cutera stock had its Relative Strength (RS) Rating upgraded to 90 from 80 a day earlier. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
Upgrades 
Via Benzinga
Expert Ratings for ShockWave Medical
Over the past 3 months, 5 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
Ulta Beauty To $511? Here Are 5 Other Price Target Changes For Monday
Barclays boosted the price target on Ulta Beauty, Inc. (NASDAQ: ULTA) from $491 to $511. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Ulta Beauty shares fell 1% to... 
Via Benzinga
ShockWave Stuns With 40% Post-Earnings Price Move: Is It A Buy?
Shockwave Medical bolted 40% higher since its second-quarter earnings report on August 8. It's currently trading at new highs, but is it the right time to buy? 
Via MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
The major indexes continued to advance, despite some key warnings. 
Via Investor's Business Daily
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
On Tuesday, InMode stock got a positive adjustment to its Relative Strength (RS) Rating, to 86 from 72 a day earlier. 
Via Investor's Business Daily
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
  Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The... 
Via Benzinga
Dow Jones Giant UnitedHealth Breaks Out, Leading 5 Stocks To Watch
UNH stock and AbbVie boast favorable tailwinds, including the market's defensive tilt. 
Via Investor's Business Daily
Earnings Scheduled For August 8, 2022
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.